England: Shionogi And Pfizer Ink ‘World First’ Payment Model Deal For Antibiotics
Shionogi and Pfizer have formally agreed to a scheme that offers companies a new and sustainable payment model for innovating in antibiotics.
You may also be interested in...
More should be done to incentivize comparative clinical trials so as to allow better decisions on drug pricing to be taken, said Austria’s representative at a recent meeting of EU health ministers.
Five Nordic countries are agreeing a common strategy for closer collaboration on access to hospital drugs.
Companies are initially expected to fund drugs for individual patients under a Dutch pilot for improving access to orphan drugs.